RIVERSIDE, CA--(Marketwire - July 27, 2012) - Ingen Technologies, Inc. (PINKSHEETS: IGNT), an emerging medical device manufacturer with proprietary medical products for the growing $4B respiratory markets, announced today that the company has finalized its sales program with one of the largest medical suppliers in North America. All sales, e-commerce and business-to-business will be provided through this major supplier. The Ingen website is now being rebuilt to reflect the new medical supplier and national sales program. Ingen expects to have this transition complete in the next several weeks, at which time an announcement will be made.
Ingen is licensed in the State of California with the Department of Public Health to manufacture its Oxyview and Smart Nasal Cannula product line. These patented & proprietary medical products are now globally distributed to the respiratory industry and registered with the U.S. FDA (Food & Drug Administration). Please refer to the most recent Annual Report ending May 31, 2012 for current information about the medical technologies owned and manufactured by Ingen. This report is found at the following link: http://www.otcmarkets.com/financialReportViewer?symbol=IGNT&id=86111
Further, Ingen has been negotiating for several months with another large medical supplier who is a major player in selling medical products to various government medical facilities. "We are now directing our focus on closing this agreement in order to deliver products to VA Hospitals and to the Department of Defense. We received a GSA Department of Veterans Affairs Federal Supply Contract Award in 2011 and will distribute our medical products to VA Hospitals and to the Department of Defense in 2013," stated the Chairman, Gary B. Tilden.
FOR MORE UPDATED INFORMATION USE THE FOLLOWING LINK: www.otcfn.com/ignt
Also please note that the following link will direct you to the latest product video on the IGNT website:
Safe Harbor for Forward-Looking Statements: This news release includes forward-looking statements. While these statements are made to convey to the public the company's progress, business opportunities and growth prospects, readers are cautioned that such forward-looking statements represent management's opinion. Whereas management believes such representations to be true and accurate based on information and data available to the company at this time, actual results may differ materially from those described. The company's operations and business prospects are always subject to risk and uncertainties. Important factors that may cause actual results to differ are and will be set forth in the company's periodic filings with the U.S. Securities and Exchange Commission.